Abstract

To evaluate the impact of the meningococcal A (MenA) vaccine introduction in Mali through mass campaigns on the routine immunization program and the wider health system. We used a mixed-methods case-study design, combining semi-structured interviews with 31 key informants, a survey among 18 health facilities, and analysis of routine health facility data on number of routine vaccinations and antenatal consultations before, during, and after the MenA vaccine campaign in December 2010. Survey and interview data were collected at the national level and in 2 regions in July and August 2011, with additional interviews in January 2012. Many health system functions were not affected-either positively or negatively-by the MenA vaccine introduction. The majority of effects were felt on the immunization program. Benefits included strengthened communication and social mobilization, surveillance, and provider skills. Drawbacks included the interruption of routine vaccination services in the majority of health facilities surveyed (67%). The average daily number of children receiving routine vaccinations was 79% to 87% lower during the 10-day campaign period than during other periods of the month. Antenatal care consultations were also reduced during the campaign period by 10% to 15%. Key informants argued that, with an average of 14 campaigns per year, mass campaigns would have a substantial cumulative negative effect on routine health services. Many also argued that the MenA campaign missed potential opportunities for health systems strengthening because integration with other health services was lacking. The MenA vaccine introduction interrupted routine vaccination and other health services. When introducing a new vaccine through a campaign, coverage of routine health services should be monitored alongside campaign vaccine coverage to highlight where and how long services are disrupted and to mitigate risks to routine services.

Highlights

  • A s countries introduce new vaccines at an everincreasing pace, there have been concerns about the effect on immunization programs and health systems.[1]

  • When introducing a new vaccine through a campaign, coverage of routine health services should be monitored alongside campaign vaccine coverage to highlight where and how long services are disrupted and to mitigate risks to routine services

  • This study aimed to evaluate the impact of introducing the meningococcal A (MenA) vaccine on the routine immunization program and the wider health system in Mali during the second phase of the MenA vaccine introduction

Read more

Summary

Introduction

A s countries introduce new vaccines at an everincreasing pace, there have been concerns about the effect on immunization programs and health systems.[1] There is limited evidence, on the effects of introducing new vaccines on health systems. Global Health: Science and Practice 2014 | Volume 2 | Number 1 studies and that research seldom focused on lowincome countries, such as Mali, where health systems are generally weaker.[2]. Broader studies have shown that vertical disease control programs can have both positive and negative effects on the wider health system.[3,4,5,6,7] Such findings have led to regular calls for a more integrated approach to implementing communicable disease programs.[4,8,9,10,11,12,13]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call